Best-in-class partners. Curated for your study.
The Celéri Research Group is not a fixed CRO bundle. It is a curated network of specialist partners — CRO, biostatistics, GxP quality, regulatory strategy, medical writing, scientific communications, and SDOH data — assembled around what your study actually needs, on Celéri Health's own Part 11-ready evidence infrastructure. You contract only for what applies.
Not a fixed CRO. A curated partner network.
Most CRO relationships lock you into a single firm's capabilities — and you pay for everything they offer, whether your study needs it or not. The Celéri Research Group works differently.
Celéri Health maintains relationships with specialist partners across every dimension of clinical research and assembles the right combination for your study, stage, and budget. Sponsors and clinician-researchers get capabilities that would normally require multiple separate vendor relationships, coordinated through a single point of contact — with data captured on Celéri Health's own Part 11-ready EDC from day one.
You contract only for what you need. As the study evolves, the partner mix evolves with it.
Define the objective
We start with your study goal, regulatory pathway, timeline, and budget — not a service menu. That context determines which partners belong at the table.
Curate the partner set
From CRO and biostatistics to regulatory, medical writing, and scientific communications, Celéri Health identifies the right combination for the study as designed.
Contract only what applies
No bundled services you won't use. No overhead from capabilities that don't fit. Engagements are scoped to the study's actual requirements and fixed at award.
Celéri Health coordinates
One point of contact across the full stack, from protocol design through publication — and one governed dataset underneath all of it.
Researchers and sponsors. Different needs. Same network.
The Research Group supports two engagement types, each drawing on the same partner network and scoped differently.
For clinician-researchers running their own studies.
If you're planning an investigator-initiated study or trial, the Research Group can help from day one — study design, electronic data capture, PRO selection, IRB submission, and site coordination — with access to the Celéri Pain Research Network and PatientFinder™ recruitment.
- Study design and protocol development
- Central IRB submission support
- Electronic CRFs and ePRO instruments on Celéri Health's EDC
- Site access across the Celéri Pain Research Network
- PatientFinder™ patient identification and recruitment
- Medical writing, abstract, and publication support
For medtech and pharma sponsors at any stage of development.
The Research Group supports the full trial spectrum — IDE through post-market — for sponsors who need evidence infrastructure for a device or therapeutic. Registry experience across interventional pain and neuromodulation delivers data structured for real-world evidence requirements, regulatory submissions, and payer access.
- Full-service CRO coordination, scaled to the study
- IDE, PMA supplement, 510(k), and post-market study design
- Regulatory strategy and consultant access
- Biostatistics and HEOR support
- Site monitoring and data management
- KOL identification and engagement
Specialist partners across every dimension of clinical research.
Celéri Health doesn't maintain one vendor for every capability. It curates partners who are best-in-class in their domain. The named partners below are the core of the network; additional specialists are engaged as a study requires.
Celéri Health
Proprietary EaaS™ Platform and Part 11-ready EDC, EHR integrations, ePRO delivery, de-identification, and data stewardship — operated in-house under Celéri Health's quality management system. Central IRB submissions, eConsent, and determinations are coordinated in-house, under a quality system built with KV Consulting Firm for inspection readiness.
- EDC
- ePRO
- Data management
- QMS
- IRB coordination
Hart Clinical Consultants
Clinical research operations for interventional pain and neuromodulation — site management, monitoring, regulatory strategy, biostatistical design, HEOR, and medical writing from clinical study reports to peer-reviewed manuscripts. Fit-to-purpose: a boutique when a boutique delivers better results.
- CRO
- FDA strategy
- Biostatistics
- HEOR
- Medical writing
KV Consulting Firm
GxP quality and regulatory consulting for medical device, pharma, and biologics — supplier qualification and GCP audits, mock FDA and BIMO inspections, 483 remediation, software and process validation, and clinical study compliance review. Offices in the US and China. Led by Katy V., who serves as Celéri Health's quality lead.
- QMS
- GCP audits
- Mock inspections
- Validation
- Regulatory submissions
Feed, The Agency
Healthcare marketing, scientific communications, and KOL narrative strategy that translate evidence into market impact — plus behavioral design for patient engagement: outreach sequencing, consent communication, and longitudinal retention that protect PRO completion.
- Sci comms
- KOL strategy
- Patient engagement
Socially Determined
Social risk data and SDOH analytics through the SocialScape® platform — 800+ normalized data elements from federal, local, commercial, and consumer sources, scored across 230M+ U.S. adults for financial strain, food insecurity, housing instability, transportation, health literacy, digital access, and social isolation. Enriches PainRWD™ Science Cloud and study cohorts with ZIP-level context for outcomes interpretation, equity analysis, and payer conversations.
- SocialScape®
- SDOH enrichment
- Social risk scoring
- Equity analysis
Celéri Pain Research Network
350+ interventional pain and neuromodulation providers running practice-level registries on Celéri Health, with readiness visible in the data. PatientFinder™ matches a practice's patient panel against protocol criteria to identify candidates before the first site visit.
- Site pool
- PatientFinder™
- Benchmarking
The curation is the service.
Every partner on this list is excellent at what it does. What Celéri Health provides is the judgment to know which combination is right for your study — and the relationships to activate it quickly. We've seen what happens when a sponsor brings in the wrong-sized CRO, the wrong data system, or skips the engagement layer entirely. The Research Group exists to prevent that.
Contract only what your study needs.
The Research Group can engage across any combination of the following, scoped to your study, your stage, and your budget.
Full-Service CRO
Boutique or larger firm, matched to the study's scale and complexity
Biostatistics
Study design, power calculations, SAP, interim analysis, publication-ready outputs
EDC and ePRO
Celéri Health's Part 11-ready EDC, 30+ validated PRO instruments, EHR integration
Quality & Compliance
QMS, GCP audits, mock FDA and BIMO inspections, and inspection readiness
Regulatory Consulting
FDA strategy, IDE applications, PMA supplements, 510(k) support
Site Monitoring
Remote and on-site monitoring, source verification, GCP compliance
Behavioral Design
Patient engagement, retention strategy, outreach optimization
KOL Identification
Key opinion leader mapping, engagement strategy, advisory board support
Medical Writing
Clinical study reports, manuscripts, abstracts, regulatory documents
Scientific Communications
Healthcare marketing and the evidence-to-market narrative
Data Management
Database design, cleaning, audit trails, regulatory-grade stewardship
Patient Recruitment
PatientFinder™ matching across the 350+ provider Celéri Pain Research Network
Tell us what you're trying to prove.
Whether you're designing your first investigator-initiated study or managing a multi-site sponsor trial, the Celéri Research Group will identify the right partner combination and get the study moving.
